Technion Hosts Zimin Foundation Visit Highlighting Advances in AI for Healthcare

Boris Zimin, founder of the Zimin Foundation, his wife, Yulia Prokhorova, a director of the foundation, and Mark Shmulevich, director of the Zimin Institutes, recently visited the Technion. They met with Prof. Shai Shen-Orr, head of the Zimin Institute for AI Solutions in Healthcare at the Technion, Dr. Mor Goldfeder, director of business development at T3, and researchers supported by the institute. The visit highlighted the institute’s support for research over more than four years and the progress of funded research toward clinical and commercial applications.

From left to right: Yulia Prokhorova, Prof. Lihi Zelnik-Manor, Boris Zimin, Mark Shmulevich, Prof. Danny Raz, Prof. Yuval GariniFrom left to right: Yulia Prokhorova,  Prof. Lihi Zelnik-Manor, Boris Zimin, Mark Shmulevich, Prof. Danny Raz, Prof. Yuval Garini

The meeting showcased the institute’s support for 16 projects across four areas: early detection and diagnosis, medical device accessibility, predictive pathology, and systems supporting clinicians and hospitals. Technion representatives also presented recent initiatives to streamline commercialization, a central goal of the Zimin program.

Researchers supported by the institute presented their latest advances and outlined their paths toward practical applications in healthcare. Dr. Gil Shamai and Prof. Ron Kimmel from the Henry and Marilyn Taub Faculty of Computer Science presented Phenotix, the company they have founded to develop an AI framework for cancer phenotyping and treatment planning. Dr. Eran Berkowitz, an ophthalmologist and head of the Glaucoma Service at HYMC, and Prof. Joachim Behar, head of the Artificial Intelligence in Medicine Laboratory (AIMLab) at the Faculty of Biomedical Engineering, presented Lumiere.ai, a company they have co-founded with Or Abramovich. The company develops a multimodal AI foundation model of the eye for disease detection and prediction. Among the Zimin Institute’s contributions to the venture is a 3D OCT foundation model developed with its support, which has helped lay the scientific groundwork for Lumiere.ai. Prof. Yoav Shechtman from the Faculty of Biomedical Engineering and the Andrew and Erna Viterbi Faculty of Electrical and Computer Engineering presented his work on a novel benchtop imaging flow cytometer. Prof. Oren Caspi, the director of the Heart Failure Unit at Rambam Health Care Campus, presented Decipher.ai, a causal AI platform he is developing with Prof. Uri Shalit from the Department of Statistics at Tel Aviv University to support clinical decision-making in cardiology.

From left to right: Dr. Mor Goldfeder, Prof. Oren Caspi, Prof. Shai Shen-Orr, Boris ZiminFrom left to right: Dr. Mor Goldfeder, Prof. Oren Caspi, Prof. Shai Shen-Orr, Boris Zimin

The researchers emphasized that support from the Zimin Institute has been instrumental in advancing their work, positioning them to secure additional funding and opening doors to new collaborations and opportunities that would otherwise have remained beyond reach.

Following the meeting with the researchers, the guests met with Prof. Lihi Zelnik-Manor, vice president for external relations and resource development; Prof. Danny Raz, senior executive vice president; and Prof. Yuval Garini, executive vice president for industry relations. The discussion explored how artificial intelligence is shaping the future of academia, including its implications for research, education, and collaboration with industry.

The visit underscored the Zimin Foundation’s continued partnership with the Technion and its role in advancing AI research with the potential to improve healthcare. It also highlighted the opportunities ahead to translate research discoveries into clinical tools and commercial ventures.